AI English summary of an SEC filing — figures as filed
Humana HUMHumana said it entered into an underwriting agreement on March 5, 2026 with the representatives of the underwriters to issue and sell $1.0 billion in principal amount of its 6.625% Fixed-to-Fixed Rate Junior Subordinated Notes due 2056 at 100.000% of principal amount.
Key points
AI summaryHumana said it entered into an underwriting agreement on March 5, 2026 with the representatives of the underwriters to issue and sell $1.0 billion in principal amount of its 6.625% Fixed-to-Fixed Rate Junior Subordinated Notes due 2056 at 100.000% of principal amount.
The company estimated net proceeds of about $986 million after deducting underwriting discounts and commissions and estimated offering expenses. It said it plans to use the proceeds for general corporate purposes, which may include repaying existing indebtedness, including borrowings under its commercial paper program.
The company said the notes bear interest at 6.625% per year until September 15, 2031, after which the rate will reset every 5 years to the five-year U.S. Treasury Rate plus 2.891%, but will not reset below 6.625%. The notes mature on September 15, 2056. If no event of default has occurred and is continuing, the company may defer interest for up to 10 consecutive years.
Humana said it completed the public offering of the notes on March 9, 2026. The notes are unsecured subordinated obligations that rank junior in right of payment to all Senior Indebtedness, will be effectively junior to any future secured indebtedness to the extent of the assets securing it, and will be structurally subordinated to the liabilities of its subsidiaries.
Summary
AI-writtenAnalysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
$1.0 billion Junior Subordinated Notes Agreement
Humana said it entered into an underwriting agreement on March 5, 2026 with the representatives of the underwriters to issue and sell $1.0 billion in principal amount of its 6.625% Fixed-to-Fixed Rate Junior Subordinated Notes due 2056 at 100.000% of principal amount.
Source · Based on the filing body and exhibits
About $986 million Net Proceeds and Use of Funds
The company estimated net proceeds of about $986 million after deducting underwriting discounts and commissions and estimated offering expenses. It said it plans to use the proceeds for general corporate purposes, which may include repaying existing indebtedness, including borrowings under its commercial paper program.
Source · Based on the filing body and exhibits
Interest Rate Structure and Interest Deferral Terms
The company said the notes bear interest at 6.625% per year until September 15, 2031, after which the rate will reset every 5 years to the five-year U.S. Treasury Rate plus 2.891%, but will not reset below 6.625%. The notes mature on September 15, 2056. If no event of default has occurred and is continuing, the company may defer interest for up to 10 consecutive years.
Source · Based on the filing body and exhibits
Completion of March 9, 2026 Offering and Ranking of Debt
Humana said it completed the public offering of the notes on March 9, 2026. The notes are unsecured subordinated obligations that rank junior in right of payment to all Senior Indebtedness, will be effectively junior to any future secured indebtedness to the extent of the assets securing it, and will be structurally subordinated to the liabilities of its subsidiaries.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…